Clinical Trials for Hormone Receptor Positive Tumor

Find clinical trials for hormone receptor positive tumor. Discover research opportunities and treatment options in your area.

7 Active Trials Found

Showing 7 trials on this page

Page 1 of 1

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

NCT ID: NCT06982521

This clinical trial is studying two different treatment combinations for patients with a specific type of breast cancer called HR+/HER2- that has a PIK3CA mutation. The researchers want to see how ...

Not yet recruiting

Phase: PHASE3 Type: interventional

Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer

NCT ID: NCT05735080

This clinical trial is studying a new oral medication called INX-315, which is being developed to treat advanced cancers, specifically hormone receptor-positive breast cancer and certain types of o...

Recruiting

Phase: PHASE1 Type: interventional Locations: Boston, Massachusetts, United States, Detroit, Michigan, United States +8 more

Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy

NCT ID: NCT05582499

This clinical trial, based at Fudan University Shanghai Cancer Center, is investigating new targeted therapies for women with operable breast cancer, specifically those with early-stage or locally ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Shanghai, Shanghai, China

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

NCT ID: NCT01042379

The I-SPY Trial is a research study aimed at finding out which new medications work best for different types of breast cancer. The goal is to personalize treatment by looking at how tumors respond ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Rochester, Minnesota, United States, Los Angeles, California, United States +35 more

Adherence to Aromatase Inhibitors ± Abemaciclib Treatment in Patients With Early-stage HER2-negative Breast Cancer

NCT ID: NCT06650423

This clinical trial is studying how well patients with early-stage, hormone receptor-positive, HER2-negative breast cancer stick to their medication, particularly those taking a combination of arom...

Not yet recruiting

Type: observational

SNF Platform Study of HR+/ HER2-advanced Breast Cancer

NCT ID: NCT05594095

The SNF Platform Study is a clinical trial designed to explore new treatment options for women with advanced breast cancer that is hormone-receptor-positive and HER2-negative. This study is specifi...

Recruiting

Phase: PHASE2 Type: interventional Locations: Shanghai, Shanghai, China

A Window of Opportunity Study of Pre-operative Endocrine Therapy With and Without Prometrium in Postmenopausal Women With Early Stage Breast Hormone Receptor Positive (HR+) Human Epidermal Receptor 2 Negative (HER2-) Breast Cancer.

NCT ID: NCT03906669

This clinical trial is exploring a treatment approach for postmenopausal women with early-stage breast cancer that is hormone receptor positive (HR+) and human epidermal receptor 2 negative (HER2-)...

Recruiting

Phase: PHASE2 Type: interventional Locations: Sydney, New South Wales, Australia

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions